Erratum: Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivo

Liping Zhong1,2, Wei Shi3, Lu Gan1

  • 1National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Guangxi Medical University, Nanning, Guangxi 530021, China. Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi 530021, China.

Theranostics
|August 27, 2025
PubMed

[This corrects the article DOI: 10.7150/thno.53121.].

Related Concept Videos